86 related articles for article (PubMed ID: 992184)
1. [Cell-mediated BCG-diagnosis using a multipuncture apparatus in melanoma].
Wolf M
Dermatol Monatsschr; 1976 Sep; 162(9):756-7. PubMed ID: 992184
[No Abstract] [Full Text] [Related]
2. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
[No Abstract] [Full Text] [Related]
4. Prospective comparison of intralesional and multipuncture BCG in recurrent intradermal melanoma.
Nathanson L; Schoenfeld D; Regelson W; Colsky J; Mittelman A
Cancer; 1979 May; 43(5):1630-5. PubMed ID: 376098
[TBL] [Abstract][Full Text] [Related]
5. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
6. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
[No Abstract] [Full Text] [Related]
7. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
8. Histologic changes in the human skin melanoma after intratumorous treatment with BCG.
Svejda J; Mechl Z; Sopková B; Foukal T
Neoplasma; 1979; 26(2):215-21. PubMed ID: 471128
[TBL] [Abstract][Full Text] [Related]
9. [BCG-treatment of malignant melanoma].
Borberg H
Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254
[No Abstract] [Full Text] [Related]
10. [Immunologic reactions in malignant melanoma of the skin in man].
Veresova OV; Korosteleva TA
Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
[No Abstract] [Full Text] [Related]
11. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
12. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
13. Immunologic defects in melanoma patients: lack of effect of BCG therapy.
Gersten MJ; Hadden EM; Kaplan MH; Pinsky CM; Armstrong D; Hadden JW
Clin Bull; 1977; 7(2):63-9. PubMed ID: 902403
[No Abstract] [Full Text] [Related]
14. Immunological studies with human neoplasms.
Morton DL
J Reticuloendothel Soc; 1971 Jul; 10(1):137-60. PubMed ID: 4941264
[No Abstract] [Full Text] [Related]
15. BCG stimulation of immune responsiveness in patients with malignant melanoma. Preliminary report.
Gutterman J; Mavligit G; McBride C; Frei E; Hersh EM
Cancer; 1973 Aug; 32(2):321-7. PubMed ID: 4722915
[No Abstract] [Full Text] [Related]
16. Immunologic effects of BCG in patients with malignant melanoma: specific evidence for stimulation of the 'secondary' immune response.
Chess L; Bock GN; Ungaro PC; Buchholz DH; Mardiney MR
J Natl Cancer Inst; 1973 Jul; 51(1):57-65. PubMed ID: 4720886
[No Abstract] [Full Text] [Related]
17. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
18. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.
Krone B; Kölmel KF; Henz BM; Grange JM
Eur J Cancer; 2005 Jan; 41(1):104-17. PubMed ID: 15617995
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy].
Lejeune FJ; Bernheim JL; Vanwijck R
Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
[No Abstract] [Full Text] [Related]
20. [Immunology of melanoma].
Vanwijck R; Bernheim JL; Lejeune FJ
Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
